📊 Score Breakdown
Offering Ability
90
Cash Runway
10
Float Risk
25
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
26%
📉 Score Deterioration
40%
• Score rose 28 points recently (worsening)
💰 Capital Raise
20%
• Active shelf registration ($300M, 205% of market cap)
💹 Market Data
Market Cap$146.55M
Shares Outstanding18.53M
Float12.74M
Cash$138.22M
Debt$1.21M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 43.2% shares (2025Q4 vs prior)
101 institutional holders · 13.66M shares
#1
Cormorant Asset Management, LP
2.34M shares
#2
ORBIMED ADVISORS LLC
1.60M shares
#3
Aberdeen Group plc
1.32M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.20M
Days to Cover3.9
% of Float9.4%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2014
S-3
SHELF
Mar 11, 2026
4
INSIDER TRANSACTION
Mar 04, 2026
4
INSIDER TRANSACTION
Feb 18, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CRBP
📊 CRBP FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CRBP Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.